2017
DOI: 10.1111/cen.13496
|View full text |Cite
|
Sign up to set email alerts
|

Gain‐of‐function mutations in G‐protein–coupled receptor genes associated with human endocrine disorders

Abstract: SummaryThe human genome encodes more than 700 G-protein-coupled receptors (GPCRs), many of which are involved in hormone secretion. To date, more than 100 gain-offunction (activating) mutations in at least ten genes for GPCRs, in addition to several loss-of-function mutations, have been implicated in human endocrine disorders.Previously reported gain-of-function GPCR mutations comprise various missense substitutions, frameshift mutations, intragenic inframe deletions and copy-number gains.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 43 publications
0
18
0
Order By: Relevance
“…This hypothesis is supported by evidence that treatment with melatonin during periods of light exposure is detrimental to long-term rod photoreceptor viability 8 . Dimerization of GPCR monomers (including MT1/MT2) is widely-considered to be essential to receptor functions 48 . Fukami et al 48,49 have proposed a paradoxical gain-of-function mechanism in which most WT GPCRs reside on the cell surface as homodimers or heterodimers under basal conditions, and that the presence of mutant/WT receptor dimers on the cell surface can negatively affect the activity and/ or cellular regulation of the WT dimer partners.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This hypothesis is supported by evidence that treatment with melatonin during periods of light exposure is detrimental to long-term rod photoreceptor viability 8 . Dimerization of GPCR monomers (including MT1/MT2) is widely-considered to be essential to receptor functions 48 . Fukami et al 48,49 have proposed a paradoxical gain-of-function mechanism in which most WT GPCRs reside on the cell surface as homodimers or heterodimers under basal conditions, and that the presence of mutant/WT receptor dimers on the cell surface can negatively affect the activity and/ or cellular regulation of the WT dimer partners.…”
Section: Discussionmentioning
confidence: 99%
“…Dimerization of GPCR monomers (including MT1/MT2) is widely-considered to be essential to receptor functions 48 . Fukami et al 48,49 have proposed a paradoxical gain-of-function mechanism in which most WT GPCRs reside on the cell surface as homodimers or heterodimers under basal conditions, and that the presence of mutant/WT receptor dimers on the cell surface can negatively affect the activity and/ or cellular regulation of the WT dimer partners. The authors described a 'paradoxical' gain-of-function of the GPCR prokineticin receptor 2 (PROKR2) 49 .…”
Section: Discussionmentioning
confidence: 99%
“…A structural hypothesis on the effect of all SNVs located on ICL3 cannot be proposed at the moment giving the absence of a properly modeled domain. Solving the structure of GPR101 would constitute a great step toward a better understanding of the effects of its variants, especially since ICL3, where many of the variants are located, appears to be a hotspot for gain-offunction SNVs (Fukami et al 2018).…”
Section: Is Gpr101 Involved In Other Diseases?mentioning
confidence: 99%
“…Anomalies in GPCRs caused by polymorphisms are associated with a variety of phenotypes and predisposition to certain diseases. It has been described more than 700 mutations that inactivate or over activate receptors, which are related to over 30 different human diseases ( Schöneberg et al, 2004 ; Zalewska et al, 2014 ; Fukami et al, 2018 ). Marott, Nordestgaard et al (2013) identified genetic variants of the AT1R in patients with atrial fibrillation (AF).…”
Section: Introductionmentioning
confidence: 99%